Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.35 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
| ▸ | AURKA | O14965 | 1/20 | 0.34 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.34 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.34 |
| ▸ | PAK4 | O96013 | 1/20 | 0.34 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.34 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | CSF1R | P07333 | 1/20 | 0.34 |
| ▸ | RET | P07949 | 1/20 | 0.34 |
| ▸ | IGF1R | P08069 | 1/20 | 0.34 |
| ▸ | MET | P08581 | 1/20 | 0.34 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.34 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5633757 | 0.80 | SMPD3 (0.35) | SMPD3 | |
| SCHEMBL5633143 | 0.79 | ALDH1A1 (0.34) | CHEK1AURKADAPK3JAK2PRKD3 | |
| SCHEMBL10435570 | 0.73 | CHEK1 (0.43) | CHEK1AURKADAPK3JAK2PRKD3 | |
| SCHEMBL4003688 | 0.68 | ALDH1A1 (0.50) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| Bromide SCHEMBL2353004 | 0.67 | ALDH1A1 (0.49) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL25103902 | 0.65 | HTR6 (0.34) | — | |
| SCHEMBL12432819 | 0.65 | ALDH1A1 (0.38) | SMPD3HDAC1PSEN1PSEN2APH1B | |
| SCHEMBL31240925 | 0.65 | L3MBTL1 (0.37) | HDAC1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL20085840 | 0.65 | ALDH1A1 (0.38) | HDAC1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL25151349 | 0.65 | ALDH1A1 (0.38) | HDAC1PSEN1PSEN2APH1BNCSTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0930062-A1 | Compositions containing imidazo-pyridine derivatives for dying keratinous fibres and process | L'OREAL (FR) | 1999-07-21 | — | — | EP | claimed |
| US-7196196-B2 | Substituted imidazo[1, 2-a]-5,6,7,8-tetrahydropyridine-8-ones, method for their production and the use thereof for producing imidazo[1,2-a]pyridines | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-27 | — | — | US | disclosed |
| US-20050020620-A1 | Substituted imidazo[1, 2-a]-5,6,7,8-tetrahydropyridine-8-ones, method for their production and the use thereof for producing imidazo[1,2-a]pyridines | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-27 | — | — | US | disclosed |
| US-5980585-A | NONTOXIC; HAIR DYE | L'OREAL (FR) | 1999-11-09 | — | — | US | disclosed |
| EP-0930062-A1 | Compositions containing imidazo-pyridine derivatives for dying keratinous fibres and process | L'OREAL (FR) | 1999-07-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020620-A1 | Substituted imidazo[1, 2-a]-5,6,7,8-tetrahydropyridine-8-ones, method for their production and the use thereof for producing imidazo[1,2-a]pyridines | BTN3A1, DHPS, NISCH | SMPD3 4780/4885CHEK1 3425/4885AURKA 862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.